SynergyRx

• Provider Profile Name: SynergyRx
• Website: synergyrx.co
• Registered Address: 5830 E 2nd St, Ste 7000 #2603, Casper, WY 82609
• Provider Type: Telehealth platform; not itself a compounding pharmacy
• GLP-1 Products: Compounded semaglutide (injectable + oral dissolving tablet, from ~$200/mo); compounded tirzepatide (injectable + oral dissolving tablet, from ~$299–$347/mo); FDA-approved branded medications also available
• Pharmacy Partners: Licensed U.S. compounding pharmacies — not publicly named
• Available: All 50 states (subject to state telehealth regulations)
• Accreditation: Not confirmed

About the Provider

SynergyRx is a telemedicine platform offering online GLP-1 prescriptions, including semaglutide and tirzepatide, for eligible adults seeking medically supervised weight management, providing virtual consultations with licensed healthcare providers, home medication delivery, 24/7 patient support, and transparent self-pay pricing in all 50 states.

SynergyRx operates as a technology platform facilitating connections between patients and independent licensed medical providers, a structure that maintains appropriate separation between technology services, clinical decision-making, and pharmaceutical dispensing. According to published terms, SynergyRx itself is not a healthcare provider and does not make medical decisions. The platform handles intake processing, customer service coordination, and logistics management, while independent healthcare professionals licensed in patients’ states review patient information and determine whether GLP-1 prescriptions are medically appropriate.

SynergyRx launched in December 2025 based on its earliest public press releases. It is among the newest entrants in the GLP-1 telehealth space.

GLP-1 Compounding

SynergyRx offers multiple medication pathways, including compounded semaglutide injections, compounded tirzepatide injections, and oral dissolving tablet formulations of both medications — a meaningful differentiator from platforms that offer injection-only options, particularly for patients with needle aversion.

SynergyRx publicly lists entry pricing for compounded GLP-1 options, including semaglutide injection and oral dissolving tablet starting at $200, and tirzepatide options starting at $299–$347. The company also displays starting prices for FDA-approved brands, including Ozempic starting at $499, and Wegovy and Mounjaro starting at $947.

Partner compounding pharmacies are not publicly named. SynergyRx states it offers both FDA-approved brand-name medications and compounded GLP-1 formulations through licensed U.S. compounding pharmacies that comply with FDA and state regulations.

GLP-1 Weight Loss

• Lose pounds of fat every week
• Money Back Guarantee
• No membership or hidden fees! Everything you need is included
• Start for just $179, no insurance required + free shipping

GLP-1 for Just $179

100k MembersHSA/FSA ApprovedFrom $179

Type of Provider

SynergyRx is a telehealth technology platform. The service operates through a telemedicine model in which patients complete a detailed medical intake form, participate in a virtual consultation, and, if medically approved, receive a prescription tailored to their health history and goals.

Before each refill, the assigned provider reviews patient progress, adjusts dosing if necessary, and confirms continued safety. Monthly or quarterly check-ins are included.

No LegitScript certification, PCAB accreditation, NABP accreditation, or BBB accreditation was found for SynergyRx in public records as of March 2026. No FDA Warning Letter was found targeting SynergyRx in the September 2025 or March 2026 warning letter waves.

States Available

SynergyRx’s telemedicine services are available in all 50 U.S. states, subject to each state’s telehealth and prescribing regulations. Actual availability in any given state depends on whether a licensed provider in that state is available in the network at the time of signup. Cash-pay only; FSA/HSA accepted per company disclosures.

Telehealth Providers / Pharmacy Partners

SynergyRx is itself the telehealth platform in this context. Partner compounding pharmacies are not publicly disclosed by name. The platform’s customer support contact is support@carevalidate.com; the “carevalidate” domain suggests a parent or affiliate entity distinct from the SynergyRx brand, consistent with the white-label platform structures common in this space.

Pricing from Reviews

SynergyRx lists compounded semaglutide starting at $200/month and compounded tirzepatide starting at $299–$347/month. A money-back guarantee is advertised, subject to terms and conditions on the official website.

Overall Reviews

No significant independent patient review profile exists for SynergyRx as of March 2026, consistent with its December 2025 launch date. Public search results consist almost entirely of press release syndications and affiliate-generated content rather than verified patient accounts. No complaints, adverse event reports, or enforcement actions were found in public records.